Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7800)
All Articles published online
|
Publishing Process of This Article
|
Nov 28, 2016 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hernández-Bartolomé A, López-Rodríguez R, Borque MJ, González-Moreno L, Real-Martínez Y, García-Buey L, Moreno-Otero R, Sanz-Cameno P. Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C. World J Gastroenterol 2016; 22(44): 9744-9751 [PMID: 27956798 DOI: 10.3748/wjg.v22.i44.9744] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i44/9744.htm |
| Number | Citing Articles |
| 1 |
Amira Isaac, Tarek Maged El Sakaty, Sarah Hamdan Hussein, Hany Samir Rasmy. Angiopoietin-2 as a predictor of fibrosis regression in chronic hepatitis C virus patients after direct-acting antiviral drugs. The Egyptian Journal of Internal Medicine 2021; 33(1) doi: 10.1186/s43162-021-00086-5
|
| 2 |
Savneet Kaur, Sadam Hussain, Kailash Kolhe, Guresh Kumar, Dinesh M. Tripathi, Arvind Tomar, Pratibha Kale, Ashad Narayanan, Chaggan Bihari, Meenu Bajpai, Rakhi Maiwall, Ekta Gupta, Shiv K. Sarin. Elevated plasma ICAM1 levels predict 28-day mortality in cirrhotic patients with COVID-19 or bacterial sepsis. JHEP Reports 2021; 3(4): 100303 doi: 10.1016/j.jhepr.2021.100303
|
| 3 |
Zhong-Bin Xia, Fan-Ru Meng, Yu-Xuan Fang, Xia Wu, Chun-Wang Zhang, Ying Liu, Dan Liu, Guo-Qing Li, Fan-Bo Feng, Hai-Yang Qiu. Inhibition of NF-κB signaling pathway induces apoptosis and suppresses proliferation and angiogenesis of human fibroblast-like synovial cells in rheumatoid arthritis. Medicine 2018; 97(23): e10920 doi: 10.1097/MD.0000000000010920
|
| 4 |
Krizia Pocino, Cecilia Napodano, Mariapaola Marino, Riccardo Di Santo, Luca Miele, Nicoletta De Matthaeis, Francesca Gulli, Raffaele Saporito, Gian Ludovico Rapaccini, Gabriele Ciasca, Umberto Basile. A Comparative Study of Serum Angiogenic Biomarkers in Cirrhosis and Hepatocellular Carcinoma. Cancers 2021; 14(1): 11 doi: 10.3390/cancers14010011
|
| 5 |
Melania Manco, Nadia Panera, Annalisa Crudele, Maria Rita Braghini, Marzia Bianchi, Donatella Comparcola, Rita De Vito, Giuseppe Maggiore, Anna Alisi. Angiopoietin-2 levels correlates with disease activity in children with nonalcoholic fatty liver disease. Pediatric Research 2022; 91(7): 1781 doi: 10.1038/s41390-021-01666-5
|
| 6 |
Maham Farshidpour, Spencer Pace, Michael L. Volk. The clinical value of angiopoietin‐2 in liver diseases. Clinical Liver Disease 2022; 19(6): n/a doi: 10.1002/cld.1218
|
| 7 |
Alessia Virzì, Victor Gonzalez-Motos, Simona Tripon, Thomas F. Baumert, Joachim Lupberger. Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker Development. Journal of Clinical Medicine 2021; 10(5): 977 doi: 10.3390/jcm10050977
|
| 8 |
Amr Shaaban Hanafy, Emad Eldin Shaaban, Sheren Al Zahaby. Predictors of Fibrosis Progression in Chronic Active Hepatitis C Related Nephropathy. EMJ Hepatology 2019; : 86 doi: 10.33590/emjhepatol/10314484
|
| 9 |
David Bauer, Karin Kozbial, Philipp Schwabl, David Chromy, Benedikt Simbrunner, Albert F. Stättermayer, Matthias Pinter, Petra Steindl-Munda, Michael Trauner, Peter Ferenci, Thomas Reiberger, Mattias Mandorfer. Angiopoietin 2 levels decrease after HCV-cure and reflect the evolution of portal hypertension. Digestive and Liver Disease 2022; 54(9): 1222 doi: 10.1016/j.dld.2022.02.013
|
| 10 |
Leona Radmanic Matotek, Snjezana Zidovec-Lepej, Nikolina Salek, Adriana Vince, Neven Papic. The Impact of Liver Steatosis on Interleukin and Growth Factors Kinetics during Chronic Hepatitis C Treatment. Journal of Clinical Medicine 2024; 13(16): 4849 doi: 10.3390/jcm13164849
|
| 11 |
Leona Radmanić, Snježana Zidovec-Lepej. The Role of Stem Cell Factor, Epidermal Growth Factor and Angiopoietin-2 in HBV, HCV, HCC and NAFLD. Life 2022; 12(12): 2072 doi: 10.3390/life12122072
|
| 12 |
Savneet Kaur, Sadam Hussain, Kailash Kolhe, Guresh Kumar, Dinesh M Tripathi, Arvind Tomar, Pratibha Kale, Ashad Narayanan, Chaggan Bihari, Meenu Bajpai, Rakhi Maiwall, Ekta Gupta, Shiv Kumar Sarin. Elevated Plasma Levels of ICAM1 Predict Mortality in COVID-19 and Sepsis Patients with Liver Cirrhosis. SSRN Electronic Journal 2020; doi: 10.2139/ssrn.3741508
|
| 13 |
M.A. Derbak, N.V. Lizanets, O.T. Hanych, V.V. Mashura, H.Y. Mashura, O.V. Ustych, L.M. Rostoka. Lipid metabolism in patients with chronic hepatitis C, non-alcoholic fatty liver disease and obesity under the influence of treatment. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 2024; 20(2): 93 doi: 10.22141/2224-0721.20.2.2024.1369
|
| 14 |
Nancy G. Casanova, Vivian Reyes-Hernon, Taylor Gregory, Belinda Sun, Tadeo Bermudez, Matthew K. Hufford, Radu C. Oita, Sara M. Camp, Gabriela Hernandez-Molina, Jorge Rojas Serrano, Xiaoguang Sun, Jocelyn Fimbres, Mehdi Mirsaeidi, Saad Sammani, Christian Bime, Joe G. N. Garcia. Biochemical and genomic identification of novel biomarkers in progressive sarcoidosis: HBEGF, eNAMPT, and ANG-2. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.1012827
|
| 15 |
Mariya A. Derbak, Nataliya V. Lizanets, Oksana T. Hanych, Olesya M. Horlenko, Hanna Y. Mashura, Serhii O. Boiko, Nad’a Rozumyková. DYNAMICS OF FIBROTIC CHANGES IN THE LIVER AFTER THE SUCCESSFUL ERADICATION OF HEPATITIS C VIRUS IN PATIENTS WITH NAFLD. Wiadomości Lekarskie 2022; 75(10): 2392 doi: 10.36740/WLek202210113
|
| 16 |
Yosuke Osawa, Sachiyo Yoshio, Yoshihiko Aoki, Masaaki Korenaga, Masatoshi Imamura, Takashi Oide, Miku Okawara, Hironari Kawai, Yuriko Tsutsui, Yuichi Yoshida, Shiori Yoshikawa, Taizo Mori, Taiji Yamazoe, Tatsuya Kanto. Blood angiopoietin-2 predicts liver angiogenesis and fibrosis in hepatitis C patients. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01633-8
|
| 17 |
Marzia Tagliaferro, Mariapaola Marino, Valerio Basile, Krizia Pocino, Gian Ludovico Rapaccini, Gabriele Ciasca, Umberto Basile, Valeria Carnazzo. New Biomarkers in Liver Fibrosis: A Pass through the Quicksand?. Journal of Personalized Medicine 2024; 14(8): 798 doi: 10.3390/jpm14080798
|
| 18 |
Roberto Carmagnani Pestana, Manal M. Hassan, Reham Abdel-Wahab, Yehia I. Abugabal, Lauren M. Girard, Donghui Li, Ping Chang, Kanwal Raghav, Jeff Morris, Robert A. Wolff, Asif Rashid, Hesham M. Amin, Ahmed Kaseb. Clinical and prognostic significance of circulating levels of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma. Oncotarget 2018; 9(102): 37721 doi: 10.18632/oncotarget.26507
|
| 19 |
Leona Radmanić, Kristian Bodulić, Petra Šimičić, Adriana Vince, Snježana Židovec Lepej. The Effect of Treatment-Induced Viral Eradication on Cytokine and Growth Factor Expression in Chronic Hepatitis C. Viruses 2022; 14(8): 1613 doi: 10.3390/v14081613
|